Related Experiment Video
Updated: Sep 3, 2026

Analyzing Beneficial Effects of Nutritional Supplements on Intestinal Epithelial Barrier Functions During Experimental Colitis
Published on: January 5, 2017
Individualized targeted exclusion diet based on confocal laser endomicroscopy does not improve irritable bowel
Lukas Michaja Balsiger1, Jolien Schol2, Karlien Raymenants2
1Translational research in gastrointestinal disorders TARGID, KU Leuven, Leuven, Belgium; Department of biomedical research DBMR, University of Bern, Bern, Switzerland.
Background & Aims:
In the duodenum of patients with irritable bowel syndrome (IBS), acute food-induced mucosal reactions have been visualized using confocal laser endomicroscopy (CLE). In uncontrolled studies, a diet excluding trigger foods led to symptomatic improvement. Here, we aim to assess the association of food-induced alterations identified using CLE and the efficacy of a targeted diet in a controlled study.
Methods:
Double-blind, controlled, crossover study in patients with IBS. Following CLE, patients excluded up to two foods that did (= real diet) and up to two foods that did not (= sham diet) cause alterations in a randomized order. Diets were followed for four weeks each. Clinical response was defined as improving ≥50 points on the IBS symptom severity score (IBS-SSS). Healthy controls underwent the same CLE protocol as patients with IBS.
Results:
Altered mucosa was visualized in all patients either before (11%) or after food administration. Clinical response rates were not different between real and sham diet (42% vs 36%, OR = 1.33, p = 0.6). Symptoms improved both on the real and the sham diet (-30 vs -20; p = 0.7). Also, in 15 healthy volunteers, altered mucosa was visualized in 100% of the exams either at baseline (13%) or after food administration.
Conclusions:
Acute alterations visualized using CLE have poor sensitivity and specificity for dietary responses in IBS patients. Moreover, altered mucosa was present in 100% of healthy volunteers and likely represents a non-specific mucosal reaction to food exposure rather than pathology, challenging the use of CLE in clinical practice to identify culprit foods. (clinicaltrials.gov: NCT05097872).
Related Concept Videos
Inflammatory Bowel Disease III: Diagnostic Studies and Management I-Nutritional Therapy
Diagnostic studies
A colonoscopy is the definitive screening test, distinguishing ulcerative colitis from other colon diseases with similar symptoms. During a colonoscopy test, inflamed mucosa with exudate ulcerations can be observed, and biopsies are taken to determine the histologic characteristics of the colonic...
Drugs for Treatment of Constipation-Predominant IBS
Irritable Bowel Syndrome II: Clinical Features and Diagnostic Evaluation
Irritable Bowel Syndrome (IBS) is classified into subtypes based on the predominant bowel habits as determined by the Bristol Stool Form Scale (BSFS). The subtypes are:
Drugs for Treatment of Diarrhea-Predominant IBS
Two specific drugs used in the treatment are alosetron (Lotronex) and eluxadoline (Viberzi). Alosetron, a 5-HT3 antagonist, works by slowing the movement of stools in the gut, reducing bowel...
Inflammatory Bowel Disease V: Surgical Management
Here are some common surgical interventions for IBD:
Irritable Bowel Syndrome I: Introduction
IBS is a chronic condition that can persist over a long period or recur frequently.
The pathogenesis of IBS involves a complex interplay of the following factors:
Altered...